- cafead Oct 19, 2023 at 10:12: AM
via Beam Therapeutics said on Thursday it plans to reduce its headcount by about 100 employees, or 20% of its current workforce, as part of a restructuring plan.
The company said it will focus on developing its experimental sickle cell disease treatment and its program for alpha-1 antitrypsin deficiency (AATD), a condition that raises risk for lung and other diseases.
article source
The company said it will focus on developing its experimental sickle cell disease treatment and its program for alpha-1 antitrypsin deficiency (AATD), a condition that raises risk for lung and other diseases.
article source